On November 2nd, Danish pharmaceutical company Novo Nordisk released its financial report for the first nine months of 2023. According to the financial report, in the first three quarters, Novo Nordisk's net sales reached DKK 166.398 billion, a year-on-year increase of 29%; The net profit was DKK 61.72 billion, a year-on-year increase of 47%.